Stay updated on Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s displayed software/theme revision was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the site's version history.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision: v3.4.2 is now displayed and the previous government funding lapse notice (v3.4.1) has been removed.SummaryDifference0.4%

- Check98 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status; updated to Revision: v3.4.1 (removing Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.